About Ascension Alexian Brothers - Elk Grove Village
"Ascension Alexian Brothers is a critical care hospital and ER with advanced specialty care services."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ascension Alexian Brothers - Elk Grove Village
During the past decade, Ascension Alexian Brothers - Elk Grove Village conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 10 clinical trials were completed, i.e. on
average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
Completed
200
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Alexian Brothers - Elk Grove Village"
#1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Ascension Alexian Brothers - Elk Grove Village
According to Clinical.Site data, the most researched conditions in "Ascension Alexian Brothers - Elk Grove Village" are
"Recurrent Breast Carcinoma" (4 trials), "Breast Adenocarcinoma" (2 trials), "Recurrent Lung Non-Small Cell Carcinoma" (2 trials), "Stage I Chronic Lymphocytic Leukemia" (2 trials) and "Stage IA Breast Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Ascension Alexian Brothers - Elk Grove Village" in a lesser frequency.
Clinical Trials Intervention Types at Ascension Alexian Brothers - Elk Grove Village
Most popular intervention types in "Ascension Alexian Brothers - Elk Grove Village" are "Drug" (14 trials), "Other" (14 trials), "Biological" (11 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Cyclophosphamide" (5 trials), "Quality-of-Life Assessment" (5 trials), "Rituximab" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Ascension Alexian Brothers - Elk Grove Village
The vast majority of trials in "Ascension Alexian Brothers - Elk Grove Village" are
11 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Ascension Alexian Brothers - Elk Grove Village
Currently, there are NaN active trials in "Ascension Alexian Brothers - Elk Grove Village".
undefined are not yet recruiting,
1 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Ascension Alexian Brothers - Elk Grove Village,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ascension Alexian Brothers - Elk Grove Village, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".